Novel liver vein deprivation technique that promotes increased residual liver volume (with <uri xlink:href="https://f6publishing.blob.core.windows.net/465fad9a-9dab-4151-87c3-9f951f3f552f/WJCC-10-11579-video.mp4" xmlns:xlink="http://www.w3.org/1999/xlink">video): A case report

Table 1 Volumetric data

Time	LHL volume (cm3)	Relative FLR increase (%)	FLR/BW, %	LHL volume /SLV (%)
BO	381.7	/	0.64	34.18
POD 1	485.9	27.3	0.81	43.52
POD 10	757.1	98.4	1.26	67.80
POD 60	787.4	106.3	1.31	70.52
POD 90	810.5	112.4	1.35	72.58

POD: Postoperative day; LHL: Left hemi liver; FLR: Future liver remnant; BO: Before operation; SLV: Standardized liver volume; BW: Body weight.

Table 2 Perioperative data

Time	AST, U/L	ALT, U/L	TBIL, μmmol/L	DBIL, μmmol/L	Alb, g/L	INR	PT, s
BO	38	63	8.8	3.9	37.2	1.02	11.4
POD 1 (STAGE 1)	402	567	14.1	5.6	29.7	1.15	12.8
POD 3 (STAGE 1)	141	365	13.4	5.7	30.4	1.11	12.4
POD 5 (STAGE 1)	74	245	12.5	5.6	31.7	1.12	12.3
POD 7 (STAGE 1)	56	168	10.4	4.5	31.1	1.12	12.5
POD 9 (STAGE 1)	47	113	21.7	8.4	34.8	1.11	13.8
POD 1 (STAGE 2)	320	203	31.5	13.5	30.0	1.30	14.4
POD 3 (STAGE 2)	143	144	16.6	5.2	23.1	1.22	13.6
POD 5 (STAGE 2)	73	114	29.4	15.1	29.1	1.24	13.8
POD 7 (STAGE 2)	29	46	16.7	7.9	39.2	1.21	13.5

Alb: Albumin; ALT: Alanine aminotransferase; AST: Aspartate transaminase; DBIL: Serum direct bilirubin; INR: International normalized ratio; Neu: Neutrophil granulocyte; PT: Prothrombin time; TBIL: Serum total bilirubin.